Clinical trial
A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of…
NCT00239174 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00239174 |
|---|---|
| Title | A Multicenter Study to Evaluate the Efficacy and Safety of of Four Doses of SR147778 in Obese Patients |
| Official title | A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose, Multi-Center Study Evaluating the Efficacy and Safety of Four Doses of SR147778 in Obese Patients |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Obesity |
| Intervention type | Drug |
| Interventions | SR147778 |
| Enrollment | 394 |
| Start date | Nov 1, 2004 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Oct 14, 2005 |
| Last update posted | Dec 10, 2008 |
| Countries | Argentina, Australia, Finland, France, Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: